Floatz logo

Calcium folinate pentahydrate

Squamous Cell Carcinoma of the Cervix

Tarveda TherapeuticsSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Squamous Cell Carcinoma of the Cervix cohort.

Asset / SponsorPhaseRating
Opb-111001
Otsuka Novel Products GmbH
Phase 1/2CCC
Niraparib
Tarveda Therapeutics
Phase 1/2CCC
Pen-866
Tarveda Therapeutics
Phase 1/2CCC
FLUOROURACILUM
Tarveda Therapeutics
Phase 1/2CCC
Idp-001
InduPro, Inc.
Phase 1/2CCC
sl-279252
Shattuck Labs, Inc.
Phase 1CC

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →